Latest news with #DocGoInc
Business Wire
31-07-2025
- Health
- Business Wire
DocGo Launches Mobile Health Vaccination Program for the County of San Diego
NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq: DCGO) ('DocGo' or the 'Company'), a leading provider of technology-enabled mobile health and medical transportation services, today announced that it secured a new contract to begin facilitating a range of community vaccination services for The County of San Diego, California. Designed to expand access to care for underserved populations in San Diego's East and North-Central neighborhoods, this comprehensive program will be held in coordination with the county, community organizations, trusted agencies and additional groups. Vaccinations will be offered at various locations including schools, houses of worship, public parks, neighborhood centers as well as in-home. A DocGo health worker will facilitate partnerships that drive community-level action in San Diego, promoting program awareness with the goal of improving equity in immunization uptake across populations disproportionality impacted by infectious disease. DocGo is already providing mobile health services on behalf of insurance payers in San Diego to help close gaps in care and bring much needed health services to people where they are, when they need it. This new program – DocGo's first with the County of San Diego – will also help ensure individuals who are disabled, frail or lack access to transportation have access to vital vaccination treatments. 'DocGo's expansion of mobile health services in San Diego illustrates our deep commitment to bringing high quality, highly accessible care to all,' said Lee Bienstock, CEO of DocGo. 'We look forward to providing both health education and the vaccines that can help children and adults thrive, helping improve neighborhood health.' This new partnership with the County of San Diego reinforces DocGo's mission to help eliminate barriers to care by delivering trusted healthcare services directly into communities. Through innovative mobile health programs that increase access for underserved populations, DocGo remains committed to creating healthier futures—one neighborhood at a time. About DocGo DocGo is leading the proactive healthcare revolution with an innovative care delivery platform that includes mobile health services, remote patient monitoring and ambulance services. DocGo is helping to reshape the traditional four-wall healthcare system by providing high quality, highly accessible care to patients where and when they need it. DocGo's proprietary technology and relationships with a dedicated field staff of certified health professionals elevate the quality of patient care and drive business efficiencies for facilities, hospital networks and health insurance providers. With Mobile Health, DocGo empowers the full promise and potential of telehealth by facilitating healthcare treatment, in tandem with a remote physician, in the comfort of a patient's home or workplace. Together with DocGo's integrated Ambulnz medical transport services, DocGo is bridging the gap between physical and virtual care. For more information, please visit To get an inside look on how the proactive healthcare revolution is helping transform healthcare by reducing costs, increasing efficiency and improving outcomes, visit Forward-Looking Statements This press release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, regarding, among other things, the Company's plans, strategies, outcomes, and prospects, both business and financial, including the Company's provision of services and further growth in San Diego and the benefits of such services. These statements are based on the beliefs and assumptions of the Company's management. Although the Company believes that its plans, intentions and expectations reflected in or suggested by these forward-looking statements are reasonable, the Company cannot assure you that it will achieve or realize these plans, intentions, outcomes, results or expectations. Accordingly, you should not place undue reliance on such statements. All statements other than statements of historical fact are forward-looking. In some cases, these statements may be preceded by, followed by or include the words 'believes,' 'estimates,' 'expects,' 'projects,' 'forecasts,' 'may,' 'might,' 'will,' 'should,' 'could,' 'can,' 'would,' 'design,' 'potential,' 'seeks,' 'plans,' 'scheduled,' 'anticipates,' 'intends' or the negative of these terms or similar expressions. Forward-looking statements are inherently subject to substantial risks, uncertainties and assumptions, many of which are beyond the Company's control, and which may cause the Company's actual results or outcomes, or the timing of results or outcomes, to differ materially from those contained in the Company's forward-looking statements, including, but not limited to the following: the Company's ability to successfully implement its business strategy, including with respect to the provision of services in San Diego; the Company's reliance on and ability to maintain its contractual relationships with its healthcare provider partners and clients; the Company's ability to compete effectively in a highly competitive industry; the Company's ability to maintain existing contracts, including the contract to provide services in San Diego; the Company's reliance on government contracts; the Company's ability to effectively manage its growth; the Company's financial performance and future prospects; the Company's ability to deliver on its business strategies or models, plans and goals; the Company's ability to expand geographically; the Company's competitive position and opportunities, including its ability to realize the benefits from its operating model; and other risk factors included in the Company's filings with the Securities and Exchange Commission. The forward-looking statements made in this press release are based on events or circumstances as of the date on which the statements are made. The Company undertakes no obligation to update any forward-looking statements made in this press release to reflect events or circumstances after the date of this press release or to reflect new information or the occurrence of unanticipated events, except as and to the extent required by law.
Business Wire
18-06-2025
- Business
- Business Wire
DocGo Announces Upcoming Participation in the iAccess Alpha Virtual Best Ideas Summer Investment Conference 2025
NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq: DCGO) ('DocGo' or the 'Company'), a leading provider of technology-enabled mobile health and medical transportation services, today announced that the Company will participate in the iAccess Alpha Virtual Best Ideas Summer Investment Conference 2025 on June 24 and 25, 2025. Representing the Company, CEO Lee Bienstock will deliver a presentation at 1:00 ET on Tuesday, June 24, followed by one-on-one meetings with investors on Wednesday, June 25. A webcast of the event will be available on the investor relations section of DocGo's website at iAccess Alpha hosts virtual investor conferences featuring companies recommended by investors. These two-day events include webcast presentations on Day 1, followed by one-on-one meetings between company management teams and pre-qualified investors on Day 2. For more information about the iAccess Alpha Virtual Best Ideas Summer Investment Conference 2025, or to register and schedule a one-on-one meeting with DocGo, please visit the conference website at: About DocGo DocGo is leading the proactive healthcare revolution with an innovative care delivery platform that includes mobile health services, remote patient monitoring and ambulance services. DocGo is helping to reshape the traditional four-wall healthcare system by providing high quality, highly accessible care to patients where and when they need it. DocGo's proprietary technology and relationships with a dedicated field staff of certified health professionals elevate the quality of patient care and drive business efficiencies for municipalities, hospital networks and health insurance providers. With Mobile Health, DocGo empowers the full promise and potential of telehealth by facilitating healthcare treatment, in tandem with a remote advanced practice provider, in the comfort of a patient's home or workplace. Together with DocGo's integrated Ambulnz medical transport services, DocGo is bridging the gap between physical and virtual care. For more information, please visit To get an inside look on how the proactive healthcare revolution is helping transform healthcare by reducing costs, increasing efficiency and improving outcomes, visit
Business Wire
02-06-2025
- Business
- Business Wire
DocGo Announces Upcoming Participation at the Goldman Sachs 46 th Annual Global Healthcare Conference
NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq: DCGO) ('DocGo'), a leading provider of technology-enabled mobile health and medical transportation services, today announced that Lee Bienstock, Chief Executive Officer, will participate in a fireside chat at the Goldman Sachs 46 th Annual Global Healthcare Conference on Monday, June 9 th from 4:00 – 4:35 PM Eastern Time, and hold 1x1 meetings as well. A webcast of the event will be available on the investor relations section of DocGo's website at About DocGo DocGo is leading the proactive healthcare revolution with an innovative care delivery platform that includes mobile health services, remote patient monitoring and ambulance services. DocGo is helping to reshape the traditional four-wall healthcare system by providing high quality, highly accessible care to patients where and when they need it. DocGo's proprietary technology and relationships with a dedicated field staff of certified health professionals elevate the quality of patient care and drive business efficiencies for municipalities, hospital networks and health insurance providers. With Mobile Health, DocGo empowers the full promise and potential of telehealth by facilitating healthcare treatment, in tandem with a remote advanced practice provider, in the comfort of a patient's home or workplace. Together with DocGo's integrated Ambulnz medical transport services, DocGo is bridging the gap between physical and virtual care. For more information, please visit To get an inside look on how the proactive healthcare revolution is helping transform healthcare by reducing costs, increasing efficiency and improving outcomes, visit
Yahoo
19-04-2025
- Business
- Yahoo
Is DocGo Inc. (DCGO) the Best Quality Penny Stock to Buy According to Hedge Funds?
We recently published a list of 11 Best Quality Penny Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where DocGo Inc. (NASDAQ:DCGO) stands against other best quality penny stocks. The quality factor in stocks refers to companies with strong fundamentals, financial stability, and reliable performance, with an aim for resilience rather than speculative growth. Quality stocks can be proxied through several metrics – as Hsu, Kalesnik, and Kose put it in their 2019 paper: 'Quality as an investment factor is systematically associated with persistent profitability, low leverage, and stable earnings growth.' Besides that, these stocks often exhibit high revenue growth, good management practices, and a sustainable competitive advantage reflected through double-digit return on invested capital. The attractiveness of quality stocks consists in their lower volatility, defense capabilities, and ability to outperform the broad market during recessions or periods of pronounced uncertainty. In the context of penny stocks, the quality factor becomes elusive, as most penny stocks inherently lack stable fundamentals, carry higher volatility, and often possess weaker balance sheets. Nevertheless, it is still positive to find quality penny stocks, which results in a powerful blend of high growth and high return features with resilience and consistency of growth. The best quality penny stocks are likely to deliver robust high growth even during market downturns and outperform the benchmark by a wide margin. The positive effect of the quality factor on stock returns has been proven by leading researchers, such as the Asness, Frazzini, and Pedersen (2019) paper. Here's an excerpt from the paper: 'High-quality stocks have higher risk-adjusted returns than low-quality stocks… A quality-minus-junk (QMJ) factor earns significant risk-adjusted returns in U.S. and global stocks.' READ ALSO: 11 Best Fundamentally Strong Penny Stocks to Buy Now. The primary takeaway for readers is that incorporating quality penny stocks in a portfolio can boost the overall return of the portfolio per unit of risk, which has always been the ultimate goal of many successful investors. However, the quality factor tends to perform better in specific market periods, and we believe the US stock market has entered such a period for the following reasons. First, smart money tends to flock into quality stocks with stable profitability, cash flows, and strong revenue growth in periods of uncertainty. The US stock market is currently shaken by the Trump tariffs. The uncertainty persists as of April 1, as evidenced by the VIX volatility index being at a value of 31, more than 50% above the daily 200 moving average. Second, there are reasons to expect a significant deceleration in GDP and earnings growth in the first half of 2025, as the cuts in public spending as well as the tariffs uncertainty are a huge headwind for private spending and Capex – CEOs tend to be reluctant to invest heavily into the business when they lack visibility for the near-term. Consequently, the odds are that Q1 2025 earnings, once reported, will show a sequential slowdown in growth. FactSet Insight showed that the Q2 2025 earnings growth for the US stock market is expected at +7.2% YoY, significantly below the +18.2% actual for the previous 4Q 2024. Keep in mind that there's still potential for actual growth to come even lower than the +7.2% estimate. Last but not least, the S&P index remains below its daily 200 moving average, an area where nothing good tends to happen. The last time the market broke below the 200 moving average was in January 2022, which resulted in a 12-month-long bear market with an absolute drawdown of -28%, much above the current -13%. This means that the current market correction may not be over yet; if the broad market stays in red territory, it is inevitable that money will start flowing increasingly toward high-quality stocks and penny stocks, boosting their valuations. All in all, the aforementioned findings support the thesis that the quality factor will be favored over the following months, which means we might be at an opportune time to buy the best quality penny stocks. Jaromir Chalabala/ We used a stock screener to identify companies with a share price under $5.00 that have at least 20% revenue CAGR in the last 5 years and a positive net profit margin. Then we compared the list with our proprietary database of hedge funds' ownership and included in the article the top 11 stocks with the largest number of hedge funds that own the stock as of Q4 2024. The stocks are ranked in ascending order. Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter's strategy selects 14 small-cap and large-cap stocks every quarter and has returned 373.4% since May 2014, beating its benchmark by 218 percentage points ().DocGo Inc. (NASDAQ:DCGO) is a provider of mobile health and medical transportation services across 31 US states and the UK. Through its extensive network of mobile units, the company offers urgent care, chronic disease management, and remote patient monitoring services directly at patients' locations. For its services, DCGO is paid by hospitals, health systems, government agencies, and corporate partners, with money that accumulates from health insurance. DCGO also ranked sixth on our recent list of 11 Best Fundamentally Strong Penny Stocks to Buy Now. DocGo Inc. (NASDAQ:DCGO) reported Q4 2024 revenues of $120.8 million, representing a 39% decrease YoY, with the decline primarily attributed to winding down migrant-related projects. While the company maintained gross margins relative to the last year, SG&A as a percentage of revenues increased substantially in Q4, reflecting continued investments in infrastructure for future growth opportunities. The company generated $70.3 million in cash flow from operations in 2024, a significant improvement from negative $64.2 million in 2023. DocGo Inc. (NASDAQ:DCGO) is actively transitioning from crisis response work to more sustainable, evergreen revenue streams, particularly in care gap closure programs where they achieved a world-class NPS score of 86. The company's pipeline includes 27 municipal contracts, 29 health system deals, and over 120 payer and provider opportunities, with several existing health plan partners looking to significantly expand their relationship in scope and scale. For 2025, management anticipates significantly higher cash flow from operations compared to the $70 million generated in 2024. The strong guidance for 2025 suggests that the immigration-related headwinds are in the rear-view mirror, which makes us include DCGO on our list of best penny stocks to buy. Overall, DCGO ranks 9th on our list of best quality penny stocks to buy according to hedge funds. While we acknowledge the potential of DCGO to grow, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. There is an AI stock that went up since the beginning of 2025, while popular AI stocks lost around 25%. If you are looking for an AI stock that is more promising than DCGO but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock. READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires. Disclosure: None. This article is originally published at Insider Monkey.
Associated Press
13-02-2025
- Business
- Associated Press
DocGo to Announce Fourth Quarter and Full Year 2024 Results on Thursday, February 27, 2025
DocGo Inc. (Nasdaq: DCGO) ('DocGo' or the 'Company'), a leading provider of technology-enabled mobile health services, announced today that the Company will release its financial results for the fourth quarter and full year ended December 31, 2024 after the markets close on Thursday, February 27, 2025. Management will also host a conference call to discuss these results at 5:00 p.m. ET on that day. Conference call and webcast details: Thursday, February 27, 2025 5:00 p.m. ET 1-800-717-1738 (U.S.) 1-646-307-1865 (international) Conference ID: 41220 To access the Call me™ feature, which avoids the need to wait for an operator, click here. A webcast of the conference call can be accessed under Events on the Investors section of the Company's website at About DocGo DocGo is leading the proactive healthcare revolution with an innovative care delivery platform that includes mobile health services, remote patient monitoring and medical transport solutions. DocGo is helping to reshape the traditional four-wall healthcare system by providing high quality, highly accessible care to patients where and when they need it. DocGo's proprietary technology and relationships with a dedicated field staff of certified health professionals elevate the quality of patient care and drive business efficiencies for facilities, hospital networks and health insurance providers. With Mobile Health, DocGo empowers the full promise and potential of telehealth by facilitating healthcare treatment, in tandem with a remote physician, in the comfort of a patient's home or workplace. Together with DocGo's integrated Ambulnz medical transport services, DocGo is bridging the gap between physical and virtual care. For more information, please visit To get an inside look on how the proactive healthcare revolution is helping transform healthcare by reducing costs, increasing efficiency and improving outcomes, visit Mike Cole DocGo 949-444-1341 SOURCE: DocGo Inc. Copyright Business Wire 2025. PUB: 02/13/2025 07:35 AM/DISC: 02/13/2025 07:36 AM
